Community/Retail

Data show that as many as 4 million adults take a probiotic in the United States, making probiotics some of the most widely used supplements.

Pharmacy Times takes a look back into the 1920s, when the group of antibiotics was discovered.

Data compiled from a recent study show that this therapy was highly effective in preventing SHIV infection in a macaque model mimicking vaginal transmission of the virus.

The study’s results reveal that ferric maltol may offer efficiency and improved Hb levels for those with anemia.

What are the risks and benefits associated with vaccines? Mary Koslap‐Petraco DNP, PNPPC‐BC, CPNP, FAANP of Stony Brook University School of Nursing and Pediatric Nurse Practitioner House Calls explains the effects of vaccination.

Since last summer, the FDA has worked with companies to take swift action to remove any products with unacceptable impurities from the US market

The FDA recognized the role Fresenius Kabi played in helping mitigate a shortage of IV saline, specifically sodium chloride injection USP, 0.9% in bags.

Trastuzumab is indicated for the treatment of human epidermal growth factor receptor-2 (HER2) overexpressing breast cancer and HER2 overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.

Cases of SJS have been in the news lately. Here is what to know.

In late 2018, Pharmacy Times surveyed readers to determine their satisfaction levels with their jobs and salaries as pharmacists.

Vaccine misinformation is part of the growing problem that is creating a public health crisis, especially surrounding the global measles outbreak.

Dupilumab is now the first biologic therapy approved for the patient population.

There has been mixed evidence regarding whether there is an association between hormone replacement therapy (HRT) and Alzheimer disease.

What is causing the mysterious pain in this man's leg?

The findings of the study were presented in an oral abstract presentation at the Annual Conference on Retroviruses and Opportunistic Infections (CROI 2019) in Seattle, Washington.

With this approval, atezolizumab plus nab-paclitaxel is the first cancer immunotherapy regimen to be approved for breast cancer.

Dupilumab (Dupixent, Regeneron and Sanofi) would be the first FDA-approved biologic for the treatment of severe chronic rhinosinusitis with nasal polyps.

Hello and welcome to the Pharmacy Times News Network. I’m Nicole Grassano your host for our Pharmacy Week in Review.

Recently approved by the US Food and Drug Administration (FDA), the Biktarvyregimen is indicated for the treatment of adults with HIV-1 who have no history of antiretroviral therapy.

An individual treated for HIV is believed to be in long-term remission, according to experts in the United Kingdom. 'The London Patient’ is only the second documented case of sustained remission for HIV infection.

Venetoclax (Venclexta) plus obinutuzumab (Gazyva) is being developed for patients with previously-untreated chronic lymphocytic leukemia and co-existing medical conditions.

The awards will be presented at the ASHP’s Summer Meetings and the 54th Midyear Clinical Meeting.

The sNDA is based on results from the phase 3 CAPSTONE-2 study of a single dose of Xofluza compared with placebo or oseltamivir 75 mg, twice daily for 5 days, in people 12 years of age or older who are at high risk of complications from the flu.

The Priority Review is set to fast-track an application of a drug that may potentially represent a significant advancement in treatment for a serious condition.